Browse > Article
http://dx.doi.org/10.15429/jkomor.2020.20.2.138

The Anti-obesity Effects of Bangpungtongseong-san and Daesiho-tang: A Study Protocol of Randomized, Double-blinded Clinical Trial  

Oh, Jihong (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Dongguk University)
Shim, Hyeyoon (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Dongguk University)
Cha, Jiyun (Clinical Medicine Division, Korea Institute of Oriental Medicine)
Kim, Ho Seok (Clinical Medicine Division, Korea Institute of Oriental Medicine)
Kim, Min Ji (Clinical Medicine Division, Korea Institute of Oriental Medicine)
Ahn, Eun Kyung (Clinical Medicine Division, Korea Institute of Oriental Medicine)
Lee, Myeong-Jong (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Dongguk University)
Lee, Jun-Hwan (Clinical Medicine Division, Korea Institute of Oriental Medicine)
Kim, Hojun (Department of Rehabilitation Medicine of Korean Medicine, College of Korean Medicine, Dongguk University)
Publication Information
Journal of Korean Medicine for Obesity Research / v.20, no.2, 2020 , pp. 138-148 More about this Journal
Abstract
Objectives: The aim of this study is to evaluate the effects of Bangpungtongseong-san (Fangfengtongsheng-san, BTS) and Daesiho-tang (Dachaihu-tang, DST) on weight loss and improvement in lipid metabolism and glucose metabolism. Furthermore, we intend to develop a prediction model for drug effects through the analysis of the single nucleotide polymorphism (SNP), gut-microbiota, and the expression of immune-related biomarkers. Methods: This study is a single-center, randomized, double-blind, parallel-design clinical trial. One hundred twenty-eight participants will be assigned to the BTS group (n=64) and DST group (n=64). Both groups will be administered 4 g medication three times a day for up to 2 weeks. The primary outcomes is weight loss. The secondary outcomes include bioelectrical impedance analysis, waist circumstance, body mass index, total cholesterol, high-density lipoprotein, triglyceride, insulin resistance. The exploratory outcomes include 3-day dietary recall, food frequency questionnaire, quality of life questionnaire, gut microbiota analysis, immune biomarkers analysis, and SNP analysis. Assessment will be made at baseline and at week 4, 8, and 12. Conclusions: This protocol will be implemented by approval of the Institutional Review Board of Dongguk University. The results of this trial will provide a systematic evidence for the treatment of obesity and enable more precise herbal medicine prescriptions.
Keywords
Obesity; Korea traditional medicine; Randomized controlled trial; Herbal medicine;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015 ; 33(7) : 673-89.   DOI
2 Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. 2013 ; 11(9) : 639-47.   DOI
3 Koeppen-Schomerus G, Wardle J, Plomin R. A genetic analysis of weight and overweight in 4-year-old twin pairs. Int J Obes Relat Metab Disord. 2001 ; 25(6) : 838-44.   DOI
4 de Heredia FP, Gomez-Martinez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. 2012 ; 71(2) : 332- 8.   DOI
5 Organization for Economic Cooperation and Development (OECD). OECD health statistics 2020 [Internet]. Paris : OECD; 2020 [cited 2020 Oct 30]. Available from: https://www.oecd.org/health/health-data.htm.
6 Kim SJ, Cho KW, Oh CS, Lee SM. Gender Differences in Obesity-related Socioeconomic Costs. J Health Info Stat. 2020 ; 45(2) : 181-190.   DOI
7 Tanaka K, Nakanishi T. Obesity as a risk factor for various diseases: necessity of lifestyle changes for healthy aging. Appl Human Sci. 1996 ; 15(4) : 139-48.   DOI
8 Cowburn G, Hillsdon M, Hankey CR. Obesity management by life-style strategies. Br Med Bull. 1997 ; 53(2) : 389-408.   DOI
9 Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014 ; 29(4) : 405- 9.   DOI
10 Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean Society for the Study of Obesity Guideline for the management of obesity in Korea. J Obes Metab Syndr. 2019 ; 28(1) : 40-5.   DOI
11 Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the frontier of personalized medicine. Mayo Clin Proc. 2017 ; 92(12) : 1855-64.   DOI
12 Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017 ; 14(3) : 160-9.   DOI
13 Kim MK, Kim CS. Recent advances in anti-obesity agents. The Korean Journal of Medicine. 2018 ; 93(6) : 501-8.   DOI
14 Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014 ; 311(1) : 74-86.   DOI
15 Severin R, Sabbahi A, Mahmoud AM, Arena R, Phillips SA. Precision medicine in weight loss and healthy living. Prog Cardiovasc Dis. 2019 ; 62(1) : 15- 20.   DOI
16 Yanovski SZ, Yanovski JA. Toward precision approaches for the prevention and treatment of obesity. JAMA. 2018 ; 319(3) : 223-4.   DOI
17 Xu L, Zhao W, Wang D, Ma X. Chinese medicine in the battle against obesity and metabolic diseases. Front Physiol. 2018 ; 9 : 850.   DOI
18 Sui Y, Zhao HL, Wong VC, Brown N, Li XL, Kwan AK, et al. A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obes Rev. 2012 ; 13(5) : 409- 30.   DOI
19 Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009 ; 15(25) : 3073-85.   DOI
20 Han KS, Lee MJ, Kim H. Systematic review on herbal treatment for obesity in adults. Journal of Korean Medicine Rehabilitation. 2016 ; 26(4) : 23-35.   DOI
21 Park WH, Cha YY, Song YK, Park TY, Kim HJ, Chung WS, et al. The review on the study of oriental obesity pattern identification: focused on Korean research papers. Journal of Korean Medicine Rehabilitation. 2014 ; 24(2) : 83-93.
22 Song MY, Kim EK, Kong JC, Lee JH, Shin BC, Kwon KB. Inhibitory effect of Daesiho-tang(Dachaihu-tang) extracts on high-fat diet-induced obesity. Journal of Korean Medicine Rehabilitation. 2008 ; 18(3) : 41-9.
23 Park SA, Bang KS, Chang YN, Lee JH, Lee JH, Jin JS. A review on pharmacological properties of Bangpungtongsung-san in obesity. The Korean Medicine Society for the Herbal Formula Study. 2014 ; 22(2) : 25-34.   DOI
24 Choi EM, Ryu EK. Effects of Bang-Pung-Tong-Seoung-San on obese patients. Journal of Korean Medicine for Obesity Research. 2001 ; 1(1) : 69-77.
25 Hioki C, Yoshimoto K, Yoshida T. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clin Exp Pharmacol Physiol. 2004 ; 31(9) : 614-9.   DOI
26 Park JH, Lee MJ, Kim HJ, Hong SW, Lee DK, Yoo JW, et al. Efficacy and adverse events of Bangpungtongseong-san (Bofutsusho-san) and Bangkihwangki-tang (Boiogiot-tang) by oriental obesity pattern identification on obese subjects: randomized, double blind, placebo-controlled trial. Journal of Korean Medicine Rehabilitation. 2011 ; 21(2) : 265-78.
27 Han K, Kwon O, Park HJ, Jung SY, Yang C, Son CG. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. Trials. 2020 ; 21(1) : 128.   DOI
28 World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva : World Health Organization. 2011.
29 KIOM. Obesity Korean medicine clinical practice guideline. Seoul : Elsevier Korea. 2016 : 57-170.
30 Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev. 2007 ; 29 : 49-61.   DOI
31 Song HO, Kim SS. A literature review of single nucleotide polymorphisms in obesity genes. Journal of Korean Medicine for Obesity Research. 2004 ; 4(1) : 139-60.
32 Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020 ; 74(9) : 1251-62.   DOI
33 Llewellyn CH, Trzaskowski M, Plomin R, Wardle J. Finding the missing heritability in pediatric obesity: the contribution of genome-wide complex trait analysis. Int J Obes (Lond). 2013 ; 37(11) : 1506-9.   DOI
34 Yang J, Bakshi A, Zhu Z, Hemani G, Vinkhuyzen AA, Lee SH, et al. Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat Genet. 2015 ; 47(10) : 1114-20.   DOI
35 Park JH, Shambhunath B, Lim CY, Kim H. Impact of GNB3, ADRB3, UCP2, and PPARγ-Pro12Ala polymorphisms on Boiogito response in obese subjects: a randomized, double-blind, placebo-controlled trial. Journal of Korean Medicine for Obesity Research. 2012 ; 12(2) : 28-43.
36 Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005 ; 102(31) : 11070-5.   DOI
37 Liu J, Yue S, Yang Z, Feng W, Meng X, Wang A, et al. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. Pharmacol Res. 2018 ; 134 : 40-50.   DOI
38 Meijnikman AS, Gerdes VE, Nieuwdorp M, Herrema H. Evaluating causality of gut microbiota in obesity and diabetes in humans. Endocr Rev. 2018 ; 39(2) : 133-53.   DOI
39 Pigeyre M, Yazdi FT, Kaur Y, Meyre D. Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity. Clin Sci (Lond). 2016 ; 130(12) : 943-86.   DOI
40 Lu YM, Xie JJ, Peng CG, Wang BH, Wang KC, Li LJ. Enhancing clinical efficacy through the gut microbiota: a new field of traditional Chinese medicine. Engineering. 2019 ; 5(1) : 40-9.   DOI
41 Liu Y, Sun M, Yao H, Liu Y, Gao R. Herbal medicine for the treatment of obesity: an overview of scientific evidence from 2007 to 2017. Evid Based Complement Alternat Med. 2017 ; 2017 : 8943059.
42 Hussain A, Yadav MK, Bose S, Wang JH, Lim D, Song YK, et al. Daesiho-tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota. PLoS One. 2016 ; 11(11) : e0165483.   DOI
43 Fujisaka S, Usui I, Nawaz A, Igarashi Y, Okabe K, Furusawa Y, et al. Bofutsushosan improves gut barrier function with a bloom of Akkermansia muciniphila and improves glucose metabolism in mice with diet-induced obesity. Scientific Reports. 2020 ; 10(1) : 5544.   DOI
44 Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001 ; 280(5) : E745-51.   DOI